Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer

Sendur M. A. N., AKSOY S., YORGUN H., Ozdemir N., Yilmaz F. M., Yazici O., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.31, no.3, pp.547-556, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 31 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1185/03007995.2015.1005834
  • Journal Name: CURRENT MEDICAL RESEARCH AND OPINION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.547-556
  • Keywords: Breast cancer, HER2, Trastuzumab, Trastuzumab induced cardiotoxicity, LEFT-VENTRICULAR DYSFUNCTION, PLUS ADJUVANT CHEMOTHERAPY, RANDOMIZED-TRIAL, INDUCED CARDIOTOXICITY, FOLLOW-UP, DOXORUBICIN, BIOMARKERS, THERAPY, N9831, ERBB2
  • Gazi University Affiliated: No

Abstract

Purpose: